Skip directly to site content Skip directly to page options Skip directly to A-Z link


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
														Search
		×
			NIOSH
			NIOSH
				All CDC
				Submit
			For a full list of topics:A-Z Index
			Advanced Search
		Advanced Search


The National Institute for Occupational Safety and Health (NIOSH)


Facebook
        Twitter
        LinkedIn
        Syndicate





DISULFOTON								Related Pages
										*OSHA comments from the January 19, 1989 Final Rule on Air Contaminants Project extracted from 54FR2332 et. seq. This rule was remanded by the U.S. Circuit Court of Appeals and the limits are not currently in force.*
**CAS:** 298-04-4; **Chemical Formula:** C8H19O2PS3
OSHA formerly had no exposure limit for disulfoton. The ACGIH has a limit of 0.1 mg/m3 TWA for this substance. The proposed PEL for disulfoton was 0.1 mg/m3 as an 8-hour TWA; the final rule establishes this limit and adds a skin notation. Pure disulfoton is an oily, colorless liquid; the technical grade is a brown liquid.
The acute toxicity of disulfoton is very high by all laboratory-tested routes of administration. For weanling rats, the intraperitoneal LD(50) is reported to be 5.4 mg/kg; for adult rats, it is 9.4 mg/kg (Brodeur and Dubois 1963/Ex. 1-718). The acute dermal LD(50) is 6 mg/kg for adult female rats and 25 mg/kg for adult male rats (Gaines 1969/Ex. 1-320). The acute oral LD(50)s for male and female rats are reported as 6.8 mg/kg and 2.3 mg/kg, respectively (Brodeur and Dubois 1964/Ex. 1-1015). Rats have demonstrated an acquired tolerance for disulfoton (Brodeur and Dubois 1964/Ex. 1-1015).
Metabolically, disulfoton is highly fat-soluble, and the compound apparently interferes with mixed-function oxidase activity in the same manner shown to be the case for parathion; with respect to median lethal doses, parathion and disulfoton are similar (Stevens et al. 1973, as cited in ACGIH 1986/Ex. 1-3, p. 226).
NIOSH (Ex. 8-47, Table N2) noted that OSHA had inadvertently omitted the skin notation for the proposed limit for disulfoton. NIOSH points out that the studies described above for this substance clearly demonstrate that disulfoton “is almost as toxic via the skin as when administered internally,” and further, that the 1986 ACGIH Documentation (Ex. 1-3, p. 226) includes a skin notation for this substance. On the basis of these comments, OSHA is including a skin notation for disulfoton in the final rule. With the exception of NIOSH, no commenter submitted evidence to the record on disulfoton.
In the final rule, OSHA is establishing an 8-hour TWA PEL for disulfoton of 0.1 mg/m3, with a skin notation. The Agency concludes that this limit will prevent the significant risk of acute toxicity and metabolic injury, which are material impairments of health that are associated with exposures at levels above the new PEL. The skin notation is included to protect workers against the dermal toxicity that has been demonstrated in animal tests.
										
							
								Page last reviewed:  September 28, 2011						Content source:  	National Institute for Occupational Safety and Health NIOSH
1988 OSHA PEL Project Documentation
Index of Chemical Names
Index of CAS Numbers Follow NIOSH Facebook
Pinterest
Twitter
YouTube
 NIOSH Homepage NIOSH A-Z
Workplace Safety & Health Topics
Publications and Products
Programs
Contact NIOSH


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification / Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
				Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
				You will be subject to the destination website's privacy policy when you follow the link.
				CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue